Headache and Migraine

The Metamorphosis of Migraine: Evidence and Epidemiology

September 18, 2020

The ongoing fight to add to the epidemiologic understanding of migraine is explored in part 2 of this special 3-part multimedia series on the evolution of migraine care.

The Changing Treatment Landscape for Acute Migraine

September 18, 2020

David Dodick, MD, reviews changes to the treatment landscape for acute migraine.

Neurology Residency Training During a Pandemic

September 16, 2020

In part 2 of this interview, Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, describes how her resident program experience was impacted by the pandemic.

Episode 17: The Metamorphosis of Migraine: Discovery and Development

September 11, 2020

Mind Moments, a podcast from NeurologyLive, brings you an exclusive interview with Stewart Tepper, MD, in part 1 of this special 3-part multimedia series on the evolution of migraine care.

The Psychosocial Impact of COVID-19 in Neurology Departments

September 10, 2020

Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, shares details from her study on the psychosocial impact on physicians and her first-hand experience.

Leah Croll, MD: Psychosocial Implications of COVID-19 on Doctors

September 08, 2020

The neurology resident at NYU Langone described psychosocial implications that physicians faced during the COVID-19 pandemic and the toll it takes on them.

Migraine History Linked to Recurrent Transient Global Amnesia

September 03, 2020

Findings suggest that compared with isolated cases, both earlier age at initial episode and a higher prevalence of personal and family history of migraine are linked to TGA recurrence.

FDA Approves Ofatumumab, EVT Effective in Late Presenting Stroke, Rimegepant Safe With CGRP Antibodies

August 29, 2020

Neurology News Network for the week ending August 29, 2020.

NeurologyLive Friday 5 - August 28, 2020

August 28, 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 28, 2020.

Acute Migraine Agent Rimegepant Appears Safe With CGRP Monoclonal Antibodies

August 22, 2020

The data support and extend the safe use of combination treatment with rimegepant and CGRP monoclonal antibodies in migraine that was initially reported in 2 earlier cases.

NeurologyLive Friday 5 — August 21, 2020

August 21, 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 21, 2020.

Migraine Screening Is Not Common in Optometry Practice

August 17, 2020

A follow-up cohort study demonstrates that educating optometrists on the importance and utility of a validated migraine screening tool is a simple, low-time investment intervention, the researchers stated.